First malaria drug for newborns and infants approved in Africa
TL;DR Summary
Novartis is expected to receive approval within weeks for Coartem Baby, the first malaria treatment specifically formulated for newborns and young infants in Africa, which could significantly improve care for the most vulnerable populations and reduce malaria-related deaths among children under five.
- First malaria drug for newborns and young infants expected to be approved in Africa within weeks CNN
- First malaria treatment for babies approved for use BBC
- Novartis wins approval for first malaria drug for newborns and babies Reuters
- The first drug to treat infants sick with malaria is approved by Swiss authority AP News
- First malaria treatment for newborn babies approved for use The Washington Post
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 2 min read
Condensed
89%
366 → 42 words
Want the full story? Read the original article
Read on CNN